Implantable diagnostic device for cancer monitoring.

[1]  D Goldberg,et al.  Critical Reviews in Clinical Laboratory Sciences , 2010, Critical reviews in clinical laboratory sciences.

[2]  Y. Nagasaki,et al.  Structure and activity assay of nanozymes prepared by the coimmobilization of practically useful enzymes and hydrophilic block copolymers on gold nanoparticles. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[3]  M. Kitajima,et al.  Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells , 2008, Cancer science.

[4]  A. Kamat,et al.  Considerations on the use of diagnostic markers in management of patients with bladder cancer , 2008, World Journal of Urology.

[5]  J. Llamas-Elvira,et al.  Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Z. Chen.  Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer. , 2007, Current cancer drug targets.

[7]  Robert Langer,et al.  Multi-reservoir device for detecting a soluble cancer biomarker. , 2007, Lab on a chip.

[8]  Robert Langer,et al.  Magnetic relaxation switch detection of human chorionic gonadotrophin. , 2007, Bioconjugate chemistry.

[9]  Richard G. Moore,et al.  Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment. , 2007, Gynecologic oncology.

[10]  W. Carney.  Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers , 2007, Expert review of molecular diagnostics.

[11]  Ralph Weissleder,et al.  Continuous analyte sensing with magnetic nanoswitches. , 2006, Small.

[12]  John T Santini,et al.  Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device , 2006, Nature Biotechnology.

[13]  F. Sweep,et al.  Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[15]  Lori J Sokoll,et al.  Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. , 2004, Clinical chemistry.

[16]  J. Llamas-Elvira,et al.  201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  P. Bertrand,et al.  Surface treatment of polycarbonate films aimed at biomedical application , 2003, Journal of biomaterials science. Polymer edition.

[18]  J. Luk,et al.  Applicability of Intraoperative Parathyroid Hormone Assay During Thyroidectomy , 2002, Annals of surgery.

[19]  A. van Dalen,et al.  Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin‐2 receptor α levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma , 2002, Cancer.

[20]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[21]  Ralph Weissleder,et al.  Magnetic Nanosensors for the Detection of Oligonucleotide Sequences. , 2001, Angewandte Chemie.

[22]  M. Duffy,et al.  Clinical Uses of Tumor Markers: A Critical Review , 2001, Critical reviews in clinical laboratory sciences.

[23]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[24]  N Wisniewski,et al.  Characterization of implantable biosensor membrane biofouling , 2000, Fresenius' journal of analytical chemistry.

[25]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[26]  J. Brédas,et al.  Excimer laser-induced surface modifications of biocompatible polymer blends , 1996 .

[27]  M. Grossmann,et al.  Measurement of human chorionic gonadotropin‐related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies , 1995, European journal of clinical investigation.

[28]  A. Gerbes,et al.  Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors. , 1992, Cancer research.